In this study, we found that patients in the IPM-HR group had higher proportions of CD8+ T cells and Tregs but lower fractions of eosinophils and CD4+ memory resting T cells than the IPM-LR group in non-M3 AML patients in the TCGA cohort. Here, CD8A is linked to acute myeloid leukemia.